Baronsmead Second Venture Trust Reports 7.1% NAV Decline Amid Market Volatility
Baronsmead VCT reports 7.1% NAV dip amid market volatility, highlighting resilient unquoted holdings while navigating AIM sector challenges. New investments continue.
This article covers information on Baronsmead Second Venture Trust PLC.
LON:BMDNavigating the Headwinds: Baronsmead’s Half-Year Reality Check
Let’s cut straight to it: Baronsmead Second Venture Trust (BSVT) just reported a 7.1% drop in net asset value (NAV) per share for the six months to March 2025. That’s not a typo, and it’s certainly not business-as-usual for this stalwart of the VCT scene. The NAV slid from 55.2p to 51.3p, before ticking up to 54.1p by end-May. What’s behind the stumble? Buckle up – we’ve got political drama, market tremors, and a classic tale of public vs private equity resilience.
The Raw Numbers: More Than Just a NAV Dip
First, the headline stats:
- NAV Per Share: 51.3p (down from 55.2p at Sept 2024 end)
- Total NAV Return Since Launch (2001): 314.3p per £1 invested
- Funds Raised: £13.8mn (period) + £1.2mn (post-period)
- New Investments: £3.8mn (2 new unquoted, 9 follow-ons)
- Interim Dividend: 1.75p/share (declared for Sept 2025 payment)
The real story? That 7.1% drop wasn’t random noise. It was a tale of two portfolios…
Public vs Private: The Volatility Tug-of-War
Chair Sarah Fromson didn’t mince words: the “period of domestic and global political uncertainty” post-November 2024 (yes, that US election) hammered sentiment. But here’s where BSVT’s hybrid structure proved its mettle:
The Unquoted Portfolio (28% of NAV)
Flat as a pancake. Zero change in value. Why? Sheer diversification. 35% of holdings gained value (notably CitySwift and Panthera Biopartners), 35% held steady, and 30% dipped (Orri and Huma Therapeutics struggled with “extending sales cycles” – govt spending sectors like health felt the pinch). This is private equity’s superpower: insulation from daily market hysterics.
The AIM & Collective Funds (64% of NAV)
Ouch. Direct AIM holdings plunged 11.6% (vs AIM index -7.1%). The WS Gresham House funds took hits too: UK Micro Cap (-3.5%), Smaller Companies (-7.5%), Multi Cap Income (-11.5%). Blame? “National insurance and minimum wage increases” squeezing UK small-caps, despite >80% of portfolio companies meeting/exceeding expectations. Brutal.
Silver lining: Post-March, AIM holdings rebounded +4.8% in April (vs AIM +1.5%) and +5.3% in May. Volatility cuts both ways.
Deal Flow: Planting Seeds in a Storm
While markets wobbled, BSVT kept investing – strategically:
- New Unquoted: Mobility Mojo (disability access tech) & Much Better Adventures (bespoke travel)
- Post-Period Adds: Penfold Tech, Nu Quantum, Spinners (£2.8mn total)
- Follow-Ons: £2.3mn into 9 existing bets (including SecureCloud+ and Revlifter)
This isn’t reckless optimism. It’s the VCT playbook: deploy during downturns to capture value. As Fromson notes, this environment offers “high quality investments… at good prices.”
Realisation Realities: Cashing Chips Carefully
Exits were muted but telling:
- Partial AIM Sales: Cerillion (25.7x return!) and SEEEN generated £0.3mn
- Write-Offs: Crossword Cybersecurity (administration)
- Unquoted: No realisations. Patience prevails.
Translation: Managers harvested gains where possible but avoided fire sales. That Cerillion return? A reminder why we stomach the volatility.
Shareholder Pulse: New Blood & Dividend Discipline
Despite the NAV dip, investor appetite held firm:
- 526 new shareholders joined; 508 existing investors topped up
- £13.8mn raised (period); £1.2mn since
- Dividend policy remains anchored: targeting 7% yield on opening NAV (though “not a guarantee”)
The Board’s buyback policy (capping discounts at 5%) signals confidence – and liquidity matters in choppy markets.
Storm Clouds & Silver Linings: The Outlook
Fromson’s crystal ball is refreshingly candid:
- Headwinds: US/UK trade tariffs, recession risks, “materially damaged” confidence, subdued exit markets
- Tailwinds: Hybrid portfolio diversification, “sectors with long-term growth potential”, opportunistic pricing, elevated UK takeover activity (AIM exit upside)
Her verdict? “We remain committed to investing through the economic cycle.” Translation: Volatility isn’t an exit signal – it’s an entry point for disciplined VCTs.
The Takeaway: Grit Over Glitter
BSVT’s half-year reads like a masterclass in VCT reality: NAVs wobble, small-caps suffer whiplash, but well-structured portfolios weather storms. The 7.1% dip stings, but look deeper:
- Unquoted holdings held the line
- New capital flowed in (£15mn+ tax year to date)
- Deal flow didn’t freeze
- Dividends stayed on track
This isn’t a panic signal – it’s a reminder that VCT investing rewards marathon runners, not sprinters. As the trust navigates Labour’s Autumn Budget and Trump-era trade wars, that hybrid portfolio isn’t just diversification… it’s armour.
Disclosure: This is commentary, not advice. Always dig into the full RNS before any investment decision.
Related
Keep reading
Investing
Ashmore Group Final Results: AuM Rises 13% as Net Inflows Return
Ashmore's AuM reached US$54.0 billion as client money returned, although seed capital gains provided much of the profit growth.
JoshuaSeptember 7, 2026
Investing
ACG Metals Buys Keşkek Licence to Extend Gediktepe Gold Production
ACG Metals plans to process Keşkek oxide ore at Gediktepe, extending use of its existing gold facilities beyond the current mine plan.
JoshuaSeptember 7, 2026
Investing
SigmaRoc buys Lithuanian dolomite producer Dolomitas in €118 million deal
SigmaRoc's €118 million Dolomitas acquisition adds profitable production, long-life reserves and greater scale across the Baltic States.
JoshuaSeptember 7, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.